Wednesday, December 21, 2016

BRIEF-Concert Pharmaceuticals Inc says topline results of phase 2 trial of CTP-656 are expected by year-end 2017

* Concert Pharmaceuticals Inc says topline results of phase

2 trial of CTP-656 are expected by year-end 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)